Serum-specific IgE and allergen immunotherapy in allergic children

Immunotherapy

Volumn 6, Issue 1, 2014, Pages 29-33

  Tosca, Mariangela ^a   Sivestri, Michela ^a   Accogli, Andrea ^a   Rossi, Giovanni Arturo ^a   Ciprandi, Giorgio ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

allergen immunotherapy; allergic rhinitis; asthma; children; responder; serum specific IgE

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E;

ALLERGEN IMMUNOTHERAPY; ALLERGIC ASTHMA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOPHAGOIDES; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; LUNG FUNCTION TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHINITIS; SCHOOL CHILD; SUBLINGUAL IMMUNOTHERAPY; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADMINISTRATION, SUBLINGUAL; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CHILD; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; PYROGLYPHIDAE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 84894373118     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.13.145     Document Type: Article

References (14)

1. Jutel M, Akdis CA. Immunological mechanisms of allergen-specific immunotherapy. Allergy 66(4), 725-732 (2011).
2. Canonica GW, Bousquet J, Casale T et al. Sublingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 64(Suppl. 91), S1-S59 (2009).
3. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J. Allergy Clin. Immunol. 102(3), 558-562 (1998).
4. Vitaliti G, Leonardi S, Miraglia del Giudice M et al. Mucosal immunity and sublingual immunotherapy in respiratory disorders. J. Biol. Regul. Homeost. Agents 26(4), 85-94 (2012).
5. Di Lorenzo G, Mansueto P, Pacor ML et al. Evaluation of serum s-IgE/total-IgE ratio in predicting clinical response to allergen specific immunotherapy. J. Allergy Clin. Immunol. 123(7), 1103-1110 (2009).
6. Fujimura T, Yonekura S, Horiguchi S et al. Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis. Clin. Immunol. 139(5), 65-74 (2011).
7. Ciprandi G, Alesina R, DeAmici M. Serum specific IgE: biomarker for specific immunotherapy responsiveness? Allergol. Immunopathol. doi:10.1016/j. aller.2012.12.004 (2014) (Epub ahead of print).
8. Ciprandi G, Silvestri M, Passalacqua G, Canonica GW. Serum specific IgE: a biomarker of response to allergen immunotherapy. J. Invest. Allergol. Clin. Immunol. (In Press).
9. Bousquet PJ, Combescure C, Klossek JM et al. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J. Allergy Clin. Immunol. 123(6), 1349-1354 (2009).
10. Demoly P, Bousquet PJ, Mesbah K et al. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care. Clin. Exp. Allergy 43(7), 881-888 (2013).
11. Ciprandi G, Cadario G, Di Gioacchino M et al. Sublingual immunotherapy in polysensitized allergic patients with rhinitis and/or asthma: allergist choices and treatment efficacy. J. Biol. Reg. 23(2), 165-171 (2009).
12. Ciprandi G, Incorvaia C, Dell'Albani I et al. Patient's perception in assessing allergen immunotherapy. Allergol. Immunopathol. (In Press).
13. Howarth P, Malling HJ, Molinard M, Deviller P. Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients. Allergy 67(4), 321-327 (2012).
14. Rolinck-Werninghaus C, Keil T, Kopp M et al. Omalizumab Rhinitis Study Group. Specific IgE serum concentration is associated with symptom severity in children with seasonal allergic rhinitis. Allergy 63(9), 1339-1344 (2008).